06:24:44 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Ndatalyze Corp
Symbol NDAT
Shares Issued 26,121,425
Close 2022-04-12 C$ 0.29
Market Cap C$ 7,575,213
Recent Sedar Documents

Ndatalyze claims it has mental health issue predictor

2022-04-12 16:29 ET - News Release

Mr. James Durward reports

NDATALYZE ANNOUNCES ALL SEVEN CONDITIONS ARE FUNCTIONAL IN IT'S YMI MENTAL HEALTH DIAGNOSTIC TOOL

Ndatalyze Corp.'s YMI mental health diagnostic tool is now capable of predicting current and time forward probabilities of seven mental conditions. The conditions include anxiety, depression, OCD (obsessive-compulsive disorder), PTSD (posttraumatic stress disorder), bipolar, alcoholism and personality disorders. YMI is modelled as a machine-human hybrid "mind" designed to assist and accelerate mental health diagnosis using a foundation of objective, evidence-based data rather than traditional subjective self-reported data.

Ndatalyze's president, Jim Durward, states: "Mental health disorders are being amplified by extraordinary world events, causing elevated stress on the overall mental health system. YMI's overall objectives are to lower misdiagnosis rates, accelerate mental condition diagnosis, lower diagnosis costs and lessen the load on the overall mental health system."

The corporation reports that during the past year the following has been achieved:

  1. Established a data collection centre to gather over 1,200 biometric records, complete with same-time-of-day electroencephalogram (EEG) data. These records comprise the corporation's reference database that forms the memories of the YMI human-machine predictive mental health mind. With the data collection completed the collection centre is now closed and associated expenses eliminated;
  2. Development and testing of clinician-guided formulas and algorithms that provide supervision to YMI's predictive machine-learning processing engine;
  3. Development of a consumer-friendly front-end input website and easy-read back-end reports;
  4. Contracted an experienced product marketing team to develop and refine a comprehensive marketing plan targeting the fast-growing consumer mHealth market. The mHealth market consists of products such as FitBit, Apple watches, heart and blood monitors, DNA tests, and tele health applications;
  5. Tight cash management and a tiger team approach to software development has resulted in minimized build costs and a remaining cash balance in excess of $1.6-million with no debt.

Mr. Durward states: "I am extremely pleased with the accomplishments our team has made over the past year. In my experience, advanced products like YMI typically take much longer and cost far more to build. We are now moving to the marketing development phase and will be widening our beta testing to further refine our predictive ability, interface and reports in advance of commercial launch."

About Ndatalyze Corp.

Ndatalyze generates technology-based, health-related solutions. The YMI division is developing a machine-learning-based, on-line consumer mental health application and the MLdelic division is focusing on applying machine learning to assist in the prediction of potential benefits associated with the use of natural compounds within the mental health sector. Both YMI and MLdelic are based on the corporation's proprietary reference database consisting of over 1,200 biometric records including same-time-of-day EEG (electroencephalogram) data. With installations worldwide, its Medxtractor division manufactures small-scale bio-extractors that are used to extract compounds from a variety of botanical biomasses. While the Medxtractor division is currently generating cash flow, both YMI and MLdelic are in development and, accordingly, the corporation cannot accurately predict if or when these applications will become cash flow generators.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.